All listings for this product
About this product
- DescriptionAfter Fidel Castro came to power in 1959, his second declaration, after socialism, was that Cuba would become a leader in international science. In biotechlogy he would be proven right, and today Cuba counts a meningitis B vaccine and cutting-edge cancer therapies to its name. But how did this politically and geographically isolated country make such impressive advances? Drawing on a unique ethgraphy, and blending the insights of philosophy, sociology, and geography, The Cuban Cure shows how Cuba came to compete with U.S. pharmaceutical giants - despite a trade embargo and crippling national debt. In uncovering what is distinct about Cuban biomedical science, Simon Reid-Henry examines the forms of resistance that biotechlogy research in Cuba presents to the globalization of western models of scientific culture and practice. He illustrates the epistemic, social, and ideological clashes that take place when two cultures of research meet, and how such interactions develop as political and ecomic circumstances change.Through a vel argument about the intersection of socioecomic systems and the nature of invation, The Cuban Cure presents an illuminating study of politics and science in the context of globalization.
- Author BiographySimon Reid-Henry is lecturer in the Department of Geography at Queen Mary, University of London.
- Author(s)Simon Reid-Henry
- PublisherThe University of Chicago Press
- Date of Publication23/12/2010
- SubjectHistory: Specific Subjects
- Place of PublicationChicago, IL
- Country of PublicationUnited States
- ImprintUniversity of Chicago Press
- Weight458 g
- Width152 mm
- Height229 mm
- Spine25 mm
Best-selling in Non-Fiction Books
Save on Non-Fiction Books
- AU $57.99Trending at AU $62.11
- AU $34.67Trending at AU $36.61
- AU $73.12Trending at AU $74.82
- AU $27.64Trending at AU $35.93
- AU $18.13Trending at AU $23.76
- AU $37.59Trending at AU $40.09
- AU $34.02Trending at AU $36.09
This item doesn't belong on this page.
Thanks, we'll look into this.